Syneos Health (formerly INC Research) Developer Salaries in Raleigh-Durham, NC
The average Syneos Health (formerly INC Research) Developer in Raleigh-Durham, NC earns an estimated $102,936 annually, which includes an estimated base salary of $98,142 with a $4,794 bonus. Syneos Health (formerly INC Research) Developer compensation is $4,276 less than the US average for a Developer. Developer salaries at Syneos Health (formerly INC Research) in Raleigh-Durham, NC can range from $70,500 - $137,000.
In Raleigh-Durham, NC, The Engineering Department at Syneos Health (formerly INC Research) earns $5,688 more on average than the Sales Department.
Last updated 2 years ago.
- $98,142
- avg. base
- $4,794
- avg. bonus
Developer Salaries at Syneos Health (formerly INC Research)
In Raleigh-Durham, NC, Developers earn $2,167 more than Developers, and $5,698 less than Scrum Masters.
Compensation at Syneos Health (formerly INC Research) by Department
In Raleigh-Durham, NC, The Engineering Department averages $5,688 more than the Sales Department, and $5,697 less than the Business Development Department
Developer Compensation by Gender (All Companies)
The average female Developer at companies similar size to Syneos Health (formerly INC Research) reported making $123,753, while the average male Developer at similar sized companies reported making $124,793.
Developer Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Developer at companies similar size to Syneos Health (formerly INC Research) reported making $128,811, while the average African American/Black Developer at similar sized companies reported making $102,002.
How Developers at Syneos Health (formerly INC Research) Rate Their Compensation
The majority of Developers at Syneos Health (formerly INC Research) believe they're compensated fairly. 100% of Developers at Syneos Health (formerly INC Research) say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Syneos Health (formerly INC Research)
